Votrient (Pazopanib)
| Active Ingredient | Pazopanib |
|---|---|
| Dosage Form | Tablet |
| Available Strength | 200mg, 400mg |
| Manufacturer: | GlaxoSmithKline Pharmaceuticals Ltd |
| Packaging | 30 tablets in 1 strip |
| Therapeutic use | Kidney cancer, Soft tissue sarcoma |
| Pack Insert/Leaflet | Yes |
| Production Capacity | 1 Million Tablet's/Month |
